P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

September 2002

Features

Pharmaceutical-Approval Update

New treatments for irritable bowel syndrome, erectile dysfunction, and postherpetic neuralgia
Marvin M. Goldenberg, PhD

The Cardiac Risks of Noncardiac Medications: Should You Make Formulary Changes?

The author discusses the effects of various drugs on the cardiac QTc interval.
Alan Hopefl, PharmD

Cover Story

Complementary/Alternative Medicine Use: Responsibilities and Implications for Pharmacy Services

The increasing use of complementary and alternative remedies presents a challenge to pharmacists as they strive to ensure rational drug therapy.
Kenneth R. Cohen, PhD, RPh, Peter Cerone, MS, RPh, and Robert Ruggiero, PharmD

Short-Term Cost-Effectiveness of Bisphosphonate Therapies for Postmenopausal Osteoporotic Women at High Risk of Fracture

The authors evaluated the budget impact of risedronate and alendronate in the treatment of patients with postmenopausal osteoporosis.
D. T. Grima, MSc, R. T. Burge, PhD, D. L. Becker, MSc, and A. N. A. Tosteson, ScD

Continuing Education

Principles for Managing Vaccine Shortages

The authors review vaccines included on the recommended childhood immuzation schedule that are currently in short supply and propose suggestions for tracking patients affected by vaccine shortages.
S. Jay Weaver, PharmD, and Paul L. Doering, MS Pharm

Guest Commentary

Monitoring Dietary Supplements and Medication Errors: USP Prescription for Safety

In an effort to inform and safeguard the growing number of consumers who use dietary supplements, the U.S. Pharmacopeia (USP) has developed the Dietary Supplement Verification Program.
Miriam Reisman

Departments

Editorial

Prophylactic Ethics

Editor-in-Chief David Nash discusses “Prophylactic Ethics” in the age of genomics.
David B. Nash, MD, MBA

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Medication Errors

Can You Afford to Omit CPOE In Future Strategic Plans?

Matthew Grissinger, RPh, discusses savings that can result from implementing CPOE systems.
Matthew Grissinger

Prescription Washington

Few Marketing Obstacles in DHHS Data Privacy Rule

DHHS sets marketing hurdle for PBMs.
Stephen Barlas